BioGaia AB (publ)
BGLAF
$8.87
-$0.8517-8.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.34M | 33.82M | 29.19M | 35.93M | 35.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.34M | 33.82M | 29.19M | 35.93M | 35.58M |
| Cost of Revenue | 9.18M | 9.85M | 7.84M | 9.36M | 10.00M |
| Gross Profit | 25.16M | 23.96M | 21.35M | 26.57M | 25.57M |
| SG&A Expenses | 11.64M | 12.38M | 10.06M | 10.85M | 10.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2.28M | -- | -- | -- | -1.19M |
| Total Operating Expenses | 25.23M | 25.37M | 19.84M | 22.72M | 21.80M |
| Operating Income | 9.11M | 8.45M | 9.35M | 13.21M | 13.78M |
| Income Before Tax | 9.55M | 9.69M | 4.51M | 13.35M | 14.78M |
| Income Tax Expenses | 2.04M | 2.09M | 996.60K | 2.97M | 3.05M |
| Earnings from Continuing Operations | 7.52M | 7.59M | 3.51M | 10.38M | 11.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.52M | 7.59M | 3.51M | 10.38M | 11.72M |
| EBIT | 9.11M | 8.45M | 9.35M | 13.21M | 13.78M |
| EBITDA | 9.69M | 9.12M | 9.96M | 13.78M | 14.33M |
| EPS Basic | 0.07 | 0.08 | 0.03 | 0.10 | 0.12 |
| Normalized Basic EPS | 0.06 | 0.07 | 0.06 | 0.08 | 0.09 |
| EPS Diluted | 0.07 | 0.08 | 0.03 | 0.10 | 0.12 |
| Normalized Diluted EPS | 0.06 | 0.07 | 0.06 | 0.08 | 0.09 |
| Average Basic Shares Outstanding | 101.16M | 101.16M | 101.07M | 100.98M | 100.98M |
| Average Diluted Shares Outstanding | 101.16M | 101.16M | 101.08M | 101.00M | 100.99M |
| Dividend Per Share | -- | 0.18 | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 627.67% | -- |